Marathon Partners Equity Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,000
Closed -$813K 20
2024
Q4
$813K Buy
+15,000
New +$859K 0.71% 21
2023
Q4
$2.92M Buy
39,000
+500
+1% +$34.7K 4.55% 9
2023
Q3
$2.66M Sell
38,500
-1,500
-4% -$107K 4.04% 7
2023
Q2
$2.9M Sell
40,000
-6,000
-13% -$405K 3.6% 8
2023
Q1
$3.31M Buy
46,000
+18,500
+67% +$1.42M 4.29% 7
2022
Q4
$2.05M Buy
+27,500
New +$1.97M 3.17% 10

Other funds holding CRI

Marathon Partners Equity Management's CRI Position: Q1 2025 in Review

Marathon Partners Equity Management sold out of Carter's (CRI) in Q1 2025, closing a stake of 15,000 shares — an estimated $813K sold.

Marathon Partners Equity Management first reported a position in CRI in Q4 2022 and held it in 6 quarters. The position peaked at $3.31M in Q1 2023. 286 funds tracked by Wall St. Rank hold CRI as of Q1 2025.

  • Marathon Partners Equity Management reported no remaining Carter's position as of Q1 2025 after selling out during the quarter.
  • Marathon Partners Equity Management sold 15,000 Carter's shares in Q1 2025, an estimated $813K.
  • Marathon Partners Equity Management first reported a position in Carter's in Q4 2022 and held it in 6 quarters.
  • Marathon Partners Equity Management's Carter's position peaked at $3.31M in Q1 2023.
  • 286 funds tracked by Wall St. Rank held Carter's as of Q1 2025.

Based on Marathon Partners Equity Management's 13F filing for Q1 2025, filed 15 May 2025.